Paragon 28 (FNA) & Its Competitors Critical Comparison

Paragon 28 (NYSE:FNAGet Rating) is one of 216 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its peers? We will compare Paragon 28 to similar businesses based on the strength of its analyst recommendations, dividends, earnings, valuation, risk, institutional ownership and profitability.

Earnings and Valuation

This table compares Paragon 28 and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Paragon 28 $147.46 million -$13.69 million -43.70
Paragon 28 Competitors $1.14 billion $85.72 million -456.15

Paragon 28’s peers have higher revenue and earnings than Paragon 28. Paragon 28 is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings and price targets for Paragon 28 and its peers, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Paragon 28 0 0 6 0 3.00
Paragon 28 Competitors 646 3080 7275 163 2.62

Paragon 28 presently has a consensus target price of $26.17, suggesting a potential upside of 36.07%. As a group, “Surgical & medical instruments” companies have a potential upside of 28.20%. Given Paragon 28’s stronger consensus rating and higher probable upside, equities analysts clearly believe Paragon 28 is more favorable than its peers.


This table compares Paragon 28 and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Paragon 28 -18.54% -20.84% -13.54%
Paragon 28 Competitors -716.83% -60.47% -21.22%

Institutional & Insider Ownership

12.3% of Paragon 28 shares are held by institutional investors. Comparatively, 51.1% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 19.5% of Paragon 28 shares are held by insiders. Comparatively, 14.6% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.


Paragon 28 beats its peers on 8 of the 12 factors compared.

About Paragon 28

(Get Rating)

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with's FREE daily email newsletter.